Corbus Pharmaceuticals (CRBP) PT Raised to $52 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Corbus Pharmaceuticals (CRBP) PT Raised to $58 at Oppenheimer
March 12, 2024 5:31 PM EDTOppenheimer analyst Jeff Jones raised the price target on Corbus Pharmaceuticals (NASDAQ: CRBP) to $58.00 (from $51.00) while maintaining a Outperform rating.... More
